SunGen Pharma receives eighth ANDA approval from FDA
PRINCETON, N.J. — SunGen Pharma announced it has received its eighth ANDA approval from the US Food and Drug Administration (FDA). The eighth approved ANDA is for Lidocaine Ointment USP, 5%, Package size: 1 ½ oz tube (35.44 g). This drug product is used for production of anesthesia of accessible mucous membranes of the oropharynx.
